93 related articles for article (PubMed ID: 1510137)
41. Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilatation.
Belloni FL; Hintze TH
Am J Physiol; 1991 Sep; 261(3 Pt 2):H720-7. PubMed ID: 1909503
[TBL] [Abstract][Full Text] [Related]
42. ATP-sensitive potassium channel modulators: both pinacidil and glibenclamide produce antiarrhythmic activity during acute myocardial infarction in conscious rats.
Leprán I; Baczkó I; Varró A; Papp JG
J Pharmacol Exp Ther; 1996 Jun; 277(3):1215-20. PubMed ID: 8667181
[TBL] [Abstract][Full Text] [Related]
43. Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs.
Yao Z; Gross GJ
Am J Physiol; 1993 Jun; 264(6 Pt 2):H2221-5. PubMed ID: 8322953
[TBL] [Abstract][Full Text] [Related]
44. Cardiovascular effects of E4080, a novel bradycardiac agent with coronary vasodilating properties, in anesthetized dogs.
Kawamura T; Adachi H; Ogawa T
Eur J Pharmacol; 1991 Oct; 203(3):399-404. PubMed ID: 1773825
[TBL] [Abstract][Full Text] [Related]
45. Adenosine- and hypoxia-induced dilation of human coronary resistance arteries: evidence against the involvement of K(ATP) channels.
Lynch FM; Austin C; Heagerty AM; Izzard AS
Br J Pharmacol; 2006 Feb; 147(4):455-8. PubMed ID: 16341231
[TBL] [Abstract][Full Text] [Related]
46. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
[TBL] [Abstract][Full Text] [Related]
47. Nitroglycerin and nitroprusside increase coronary blood flow in dogs by a mechanism independent of prostaglandin release.
Panzenbeck MJ; Baez A; Kaley G
Am J Cardiol; 1984 Mar; 53(7):936-40. PubMed ID: 6422733
[TBL] [Abstract][Full Text] [Related]
48. Effect of pinacidil on myocardial blood flow in the presence of a coronary artery stenosis.
Bache RJ; Dai XZ; Baran KW
J Cardiovasc Pharmacol; 1990 Apr; 15(4):618-25. PubMed ID: 1691393
[TBL] [Abstract][Full Text] [Related]
49. Severe regional ischemia alters coronary flow reserve in the remote perfusion area.
Wu JC; Yun JJ; Dione DP; Heller EN; Deckelbaum LI; Sinusas AJ
J Nucl Cardiol; 2000; 7(1):43-52. PubMed ID: 10698234
[TBL] [Abstract][Full Text] [Related]
50. The new nitroderivative ITF 296 improves collateral blood flow in a canine model of coronary thrombosis.
Trivella MG; Barsotti G; Cereda R; Chiaverini F; Gromo G; L'Abbate A; Magnozzi D; Mizrahi J; Pelosi G; Taddei L
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S31-6. PubMed ID: 8839224
[TBL] [Abstract][Full Text] [Related]
51. Glibenclamide blunts coronary flow reserve induced by adenosine and dipyridamole.
Mortensen UM; Nielsen-Kudsk JE; Jakobsen P; Nielsen TT
Scand Cardiovasc J; 2003 Sep; 37(5):247-52. PubMed ID: 14534064
[TBL] [Abstract][Full Text] [Related]
52. Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease.
Reffelmann T; Klues HG; Hanrath P; Schwarz ER
Heart; 2002 Jan; 87(1):54-60. PubMed ID: 11751665
[TBL] [Abstract][Full Text] [Related]
53. Effect of glibenclamide on ischemic canine myocardium with glucose infusion.
Kamigaki M; Ichihara K; Kohgo Y; Abiko Y
Eur J Pharmacol; 1995 Dec; 287(2):121-6. PubMed ID: 8749025
[TBL] [Abstract][Full Text] [Related]
54. Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation.
Aversano T; Ouyang P; Silverman H
Circ Res; 1991 Sep; 69(3):618-22. PubMed ID: 1651815
[TBL] [Abstract][Full Text] [Related]
55. Effect of pinacidil on myocardial blood flow in the chronically pressure overloaded hypertrophied left ventricle.
Bache RJ; Dai XZ; Baran KW
J Cardiovasc Pharmacol; 1990 Dec; 16(6):890-5. PubMed ID: 1704980
[TBL] [Abstract][Full Text] [Related]
56. Coronary reactive hyperemia and adenosine-induced vasodilation are mediated partially by a glyburide-sensitive mechanism.
Clayton FC; Hess TA; Smith MA; Grover GJ
Pharmacology; 1992; 44(2):92-100. PubMed ID: 1570362
[TBL] [Abstract][Full Text] [Related]
57. Altered effects of potassium channel modulation in the coronary circulation in experimental hypercholesterolemia.
Mathew V; Lerman A
Atherosclerosis; 2001 Feb; 154(2):329-35. PubMed ID: 11166765
[TBL] [Abstract][Full Text] [Related]
58. Deleterious effects of vasodilating agents. Induction of subendocardial ischemia in dogs with proximal stenosis of coronary artery.
Kawashima S; Yokoyama M; Sakamoto S; Okada T; Akita H; Mizutani T; Fukuzaki H
Jpn Heart J; 1982 Nov; 23(6):951-60. PubMed ID: 7161879
[TBL] [Abstract][Full Text] [Related]
59. Effects of endothelin-1 on epicardial coronary tone, coronary blood flow, ECG-ST change and regional wall motion in anesthetized dogs.
Muramatsu K; Tomoike H; Ohara Y; Egashira S; Nakamura M
Heart Vessels; 1991; 6(4):191-6. PubMed ID: 1800477
[TBL] [Abstract][Full Text] [Related]
60. Effects of KRN2391, a novel vasodilator, on pancreatic exocrine secretion in anesthetized dogs.
Iwatsuki K; Horiuchi A; Ren LM; Chiba S
Eur J Pharmacol; 1993 Nov; 249(1):19-24. PubMed ID: 8282016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
